Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants-Reference-Cited by-同舟云学术

Pharmacokinetic Comparison of a Fixed-Dose Combination of Candesartan Cilexetil/Amlodipine/Atorvastatin Versus Co-administration of Individual Formulations in Healthy Participants

Published:2024-05-21 Issue:7 Volume:41 Page:2808-2825
ISSN:0741-238X
Container-title:Advances in Therapy
language:en
Short-container-title:Adv Ther

Author:

Kim Jae Hoon^ORCID,Song Ji Hye^ORCID,Kim MinYoung^ORCID,Hong Jang Hee^ORCID,Sunwoo Jung^ORCID,Jung Jin-Gyu^ORCID

Publisher

Springer Science and Business Media LLC

Link

https://link.springer.com/content/pdf/10.1007/s12325-024-02869-y.pdf

Reference51 articles.

1. Federal Interagency Forum on Aging-Related Statistics. Older Americans 2016: key indicators of well-being. 2016. https://agingstats.gov/docs/LatestReport/Older-Americans-2016-Key-Indicators-of-WellBeing.pdf. Accessed 2 Apr 2024.

2. Collerton J, Davies K, Jagger C, et al. Health and disease in 85 year olds: baseline findings from the Newcastle 85+ cohort study. BMJ. 2012;345:e4462–e4462. https://doi.org/10.1136/bmj.e4462.

3. Wauters M, Elseviers M, Vaes B, et al. Polypharmacy in a Belgian cohort of community-dwelling oldest old (80+). Acta Clin Belg. 2016;71(3):158–66. https://doi.org/10.1080/17843286.2016.1148298.

4. Herr M, Robine JM, Pinot J, Arvieu JJ, Ankri J. Polypharmacy and frailty: prevalence, relationship, and impact on mortality in a French sample of 2350 old people. Pharmacoepidemiol Drug Saf. 2015;24(6):637–46. https://doi.org/10.1002/pds.3772.

5. Hovstadius B, Petersson G, Hellström L, Ericson L. Trends in inappropriate drug therapy prescription in the elderly in Sweden from 2006 to 2013: assessment using national indicators. Drugs Aging. 2014;31(5):379–86. https://doi.org/10.1007/s40266-014-0165-5.